ProfileGDS4132 / 243251_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 30% 31% 41% 40% 25% 40% 32% 37% 38% 35% 42% 32% 35% 44% 32% 32% 36% 37% 38% 40% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10175.029630
GSM201543Muscle PCOS pioglitazone 12168.625531
GSM201544Muscle PCOS pioglitazone 161107.75641
GSM201545Muscle PCOS pioglitazone 201111.27140
GSM201829Muscle PCOS pioglitazone 23163.596525
GSM201830Muscle PCOS pioglitazon 251107.70140
GSM201831Muscle PCOS pioglitazone 27178.142832
GSM201832Muscle PCOS pioglitazone 3193.2237
GSM201833Muscle PCOS pioglitazone 4190.874738
GSM201834Muscle PCOS pioglitazone 8186.746235
GSM201835Muscle PCOS after pioglitazone 10294.623742
GSM201836Muscle PCOS after pioglitazone 12268.03732
GSM201837Muscle PCOS after pioglitazone 16275.199135
GSM201838Muscle PCOS after pioglitazone 202103.67344
GSM201839Muscle PCOS after pioglitazone 23272.978232
GSM201840Muscle PCOS after pioglitazone 25276.255232
GSM201841Muscle PCOS after pioglitazone 27277.575336
GSM201842Muscle PCOS after pioglitazone 3277.883337
GSM201843Muscle PCOS after pioglitazone 4293.83838
GSM201844Muscle PCOS after pioglitazone 8298.396640